In the BRAVO trial, there was a tendency for a lower incidence of postoperative complications within 90 days in the RATS group compared to the VATS group, although this difference did not reach statistical significance.
← all excerpts
Robotic-Assisted Thoracoscopic Surgery Versus Video-Assisted Thoracoscopic Surgery: Which Is the Preferred Approach for Early-Stage NSCLC?
1
—
—